Amanote Research
Register
Sign In
Discover open access scientific publications
Search, annotate, share and cite publications
Publications by T. Filleron
Successful Phase 2 Trial of Ultrafocal Brachytherapy for Low/Intermediate Risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Related publications
Low-Dose Rate Brachytherapy for Patients With Low- Or Intermediate-Risk Prostate Cancer: A Systematic Review
Canadian Urological Association Journal
Urology
Prospective Phase II Trial of Permanent Seed Implantation Prostate Brachytherapy for Intermediate-Risk Localized Prostate Cancer: Efficacy, Toxicity, and Quality of Life Outcomes
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Permanent Prostate Brachytherapy Monotherapy With I-125 for Low- And Intermediate-Risk Prostate Cancer: Outcome in 966 Patients
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Early Patient-Reported Outcomes in a Randomized Phase II Trial of HDR Monotherapy in Low and Intermediate Risk Prostate Cancer
Brachytherapy
Nuclear Medicine
Radiology
Imaging
Oncology
Toxicity and Quality of Life Report of a Phase 2 Study of Stereotactic Body Radiation Therapy (SBRT) for Low- And Intermediate-Risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Focal Low-Dose Rate Brachytherapy for the Treatment of Prostate Cancer
Cancer Management and Research
Oncology
Successful Subject Recruitment for a Prostate Cancer Behavioral Intervention Trial
Clinical Trials
Medicine
Pharmacology
Prospective Randomized Phase 2 Trial of Intensity Modulated Radiation Therapy With or Without Oncolytic Adenovirus-Mediated Cytotoxic Gene Therapy in Intermediate-Risk Prostate Cancer
International Journal of Radiation Oncology Biology Physics
Oncology
Radiology
Cancer Research
Radiation
Nuclear Medicine
Imaging
Ultra-Hypofractionated Radiation Therapy for Unfavorable Intermediate-Risk and High-Risk Prostate Cancer Is Safe and Effective: 5-Year Outcomes of a Phase II Trial
BJU International
Urology
